These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 9573573)

  • 1. Hepatorenal syndrome: definition, pathophysiology, clinical features and management.
    Bataller R; Sort P; Ginès P; Arroyo V
    Kidney Int Suppl; 1998 May; 66():S47-53. PubMed ID: 9573573
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatorenal syndrome.
    Biswas KD; Jain AK
    Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis and management of the hepatorenal syndrome.
    Laffi G; La Villa G; Gentilini P
    Semin Liver Dis; 1994 Feb; 14(1):71-81. PubMed ID: 8016664
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatorenal syndrome.
    Bataller R; Ginès P; Guevara M; Arroyo V
    Semin Liver Dis; 1997; 17(3):233-47. PubMed ID: 9308128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatorenal syndrome.
    Bataller R; Arroyo V; Ginès P; Sort P
    Forum (Genova); 1998; 8(1):62-81. PubMed ID: 9565447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment].
    Torre A; Terra C; Guevara M; Ginès P
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():8-14. PubMed ID: 15195529
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatorenal syndrome: pathophysiology and management.
    Wadei HM; Mai ML; Ahsan N; Gonwa TA
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1066-79. PubMed ID: 17699328
    [No Abstract]   [Full Text] [Related]  

  • 8. [Physiopathology of refractory ascites and the hepatorenal syndrome].
    Arroyo V
    Nefrologia; 2002; 22 Suppl 5():41-6. PubMed ID: 12107916
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of hepatorenal syndrome.
    Kiser TH; Maclaren R; Fish DN
    Pharmacotherapy; 2009 Oct; 29(10):1196-211. PubMed ID: 19792993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis.
    Angeli P; Merkel C
    J Hepatol; 2008; 48 Suppl 1():S93-103. PubMed ID: 18304678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of hepatorenal syndrome in liver cirrhosis].
    Yan M; Meng FL
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):458. PubMed ID: 15975285
    [No Abstract]   [Full Text] [Related]  

  • 12. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.
    Arroyo V; Ginès P; Gerbes AL; Dudley FJ; Gentilini P; Laffi G; Reynolds TB; Ring-Larsen H; Schölmerich J
    Hepatology; 1996 Jan; 23(1):164-76. PubMed ID: 8550036
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of the hepatorenal syndrome].
    Laffi G; Gentilini P
    Minerva Med; 1987 May; 78(10):669-74. PubMed ID: 3295597
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatorenal syndrome.
    Kramer L; Hörl WH
    Semin Nephrol; 2002 Jul; 22(4):290-301. PubMed ID: 12118394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
    Ginès P; Arroyo V; Rodés J
    Adv Intern Med; 1998; 43():99-142. PubMed ID: 9506180
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatorenal syndrome: a comprehensive overview for the critical care nurse.
    Fleming JN; Abou Abbass A
    Crit Care Nurs Clin North Am; 2010 Sep; 22(3):351-68. PubMed ID: 20691386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatorenal syndrome: pathogenesis and treatment].
    Ashkenazi E; Ilan Y; Shoval D
    Harefuah; 2007 Jun; 146(6):475-9, 499. PubMed ID: 17760404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatorenal syndrome.
    Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
    Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.
    Arroyo V; Terra C; Ginès P
    J Hepatol; 2007 May; 46(5):935-46. PubMed ID: 17391801
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatorenal syndrome].
    Lautrette A; Liotier J; Deteix P; Souweine B
    Nephrol Ther; 2009 Apr; 5(2):150-6. PubMed ID: 18514053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.